Scarica l'app Stockscreener
377.79
3.80%
-14.94
Pre-mercato:
378.42
0.63
+0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$392.73
Aprire:
$372.32
Volume 24 ore:
3.01M
Relative Volume:
2.38
Capitalizzazione di mercato:
$144.20B
Reddito:
$23.82B
Utile/perdita netta:
$2.92B
Rapporto P/E:
50.04
EPS:
7.55
Flusso di cassa netto:
$4.02B
1 W Prestazione:
-6.38%
1M Prestazione:
-4.78%
6M Prestazione:
-3.45%
1 anno Prestazione:
+13.39%
Intervallo 1D:
$372.32
$383.09
Intervallo di 1 settimana:
$372.32
$404.14
Portata 52W:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Confronta SYK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.82B | 2.92B | 4.02B | 7.55 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
What makes Stryker Corporation stock price move sharplyCapitalize on fast-moving stock opportunities - jammulinksnews.com
Does Stryker Corporation stock perform well during market downturnsIdentify undervalued stocks poised to rally - jammulinksnews.com
Stryker Corporation (NYSE:SYK) Q2 2025 Earnings Call Transcript - Insider Monkey
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say - Nasdaq
Stryker (SYK) Analyst Rating Update: Wells Fargo Raises Price Ta - GuruFocus
Stryker (SYK) Receives Price Target Boost from Baird - GuruFocus
Zimmer Biomet Holdings, Inc. shares fall 1.57% intraday as Stryker reports strong Q2 earnings. - AInvest
Stryker Remains on Pace to Benefit From a String of New Product Launches - Morningstar
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $407 to $456 - 富途牛牛
Needham Raises Price Target for Stryker (SYK) to $448, Maintains Buy Rating | SYK Stock News - GuruFocus
Why Stryker’s Stock is Gaining Momentum - TipRanks
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges - Yahoo Finance
Stryker: Q2 Earnings Snapshot - Greenwich Time
Stryker Corp Reports Strong Q2 2025 Earnings Growth - TipRanks
Earnings call transcript: Stryker Q2 2025 beats EPS and revenue forecasts - Investing.com
Stryker shares tumble despite strong Q2 results and raised guidance By Investing.com - Investing.com South Africa
Stryker shares tumble despite strong Q2 results and raised guidance - Investing.com
Stryker (NYSE:SYK) Surprises With Q2 Sales But Stock Drops - Yahoo.co
Stryker Lifts Guidance on Improving Tariff Outlook - 富途牛牛
Stryker Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Stryker earnings beat by $0.06, revenue topped estimates - Investing.com
Stryker Corp. Exceeds Expectations with Strong Q2 EarningsNews and Statistics - IndexBox
Stryker Corp (SYK) Q2 2025 Earnings: EPS at $2.29 Misses Estimates, Revenue Hits $6.0 Billion Surpassing Expectations - GuruFocus
Stryker reports second quarter 2025 operating results - The Manila Times
Grant pays for Stryker building demolition - Bryan Times
What institutional investors are buying Stryker Corporation stockAI Powered Review For 2025 - jammulinksnews.com
Colonoscopy Market Top PlayersOlympus Corporation, Stryker, - openPR.com
What Does the Market Think About Stryker? - 富途牛牛
Screener Results Flag Stryker Corporation as OversoldRisk Adjusted Technical Entry Plan Gains Followers - metal.it
Stryker launches next-generation InThrill thrombectomy system - Investing.com
Stryker launches next-generation InThrill thrombectomy system By Investing.com - Investing.com Canada
Revolutionary Small Vessel Thrombectomy System Promises Full Luminal Clot Removal: Stryker's Latest Innovation - Stock Titan
Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott - GlobeNewswire Inc.
What factors could influence SYK's earnings in the coming quarters? - AInvest
Fund Update: BRIDGES INVESTMENT MANAGEMENT INC added 38,416 shares of STRYKER ($SYK) to their portfolio - Quiver Quantitative
Clavicle Hook Plate (Fracture Fixation, Osteotomy, Malunion) Market Outlook 2025-2034 | New Advancements Propel Growth, Synthes, Zimmer Biomet, and Stryker Lead InnovationsResearchAndMarkets.com - FinancialContent
TD Cowen Maintains a Buy on Stryker Corporation (SYK) With a $435 PT - Insider Monkey
What are Stryker Corporation company’s key revenue driversFree High-Return Strategy Alerts - jammulinksnews.com
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
A Look Into Stryker Inc's Price Over Earnings - Benzinga
Is Stryker Corporation a good long term investmentAccelerated capital growth - PrintWeekIndia
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
What drives Stryker Corporation stock priceHigh-yield growth strategies - Autocar Professional
Stryker Corporation Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com
What analysts say about Stryker Corporation stockFree Wealth Planning Blueprint - jammulinksnews.com
Stryker Corporation's (NYSE:SYK) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - 富途牛牛
Lobbying Update: $230,000 of STRYKER CORPORATION lobbying was just disclosed - Nasdaq
ISRG vs. SYK: Which Robotic Surgery Stock Is the Stronger Buy Today? - Yahoo Finance
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):